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Unconventional secretion of 
α-crystallin B requires the 
Autophagic pathway and is 
controlled by phosphorylation of its 
serine 59 residue
M. D’Agostino1*, G. Scerra1, M. cannata Serio2,3, M. G. caporaso1, S. Bonatti  1 & M. Renna1*
α-Crystallin B (CRYAB or HspB5) is a chaperone member of the small heat-shock protein family that 
prevents aggregation of many cytosolic client proteins by means of its ATP-independent holdase 
activity. Surprisingly, several reports show that cRYAB exerts a protective role also extracellularly, 
and it has been recently demonstrated that CRYAB is secreted from human retinal pigment epithelial 
cells by an unconventional secretion pathway that involves multi-vesicular bodies. Here we show that 
autophagy is crucial for this unconventional secretion pathway and that phosphorylation at serine 59 
residue regulates CRYAB secretion by inhibiting its recruitment to the autophagosomes. In addition, 
we found that autophagosomes containing CRYAB are not able to fuse with lysosomes. Therefore, 
CRYAB is capable to highjack and divert autophagosomes toward the exocytic pathway, inhibiting their 
canonical route leading to the lysosomal compartment. Potential implications of these findings in the 
context of disease-associated mutant proteins turn-over are discussed.
Proteins that are secreted in an unconventional manner typically lack an N-terminal secretion signal, fail to 
traffic through the ER and Golgi and do not possess protein modifications indicative of their transit through 
the secretory pathway1. Unconventional protein secretion (UPS) was initially described for interleukin-1β and 
thioredoxin2 and so far it has been proposed for several different proteins1. These include insulin-degrading 
enzymes3, FGF-2 and galectin-14, several cytokines such as IL-1, IL-18, IL-33 and IL-1β5, nuclear proteins such 
as high mobility group protein B1 (HMGB1)6, the homeoprotein engrailed7 and Dictyostelium discoideum AcbA8 
and molecular chaperones such as BAG39. A number of diverse mechanisms for unconventional secretion, 
including both vesicular and non-vesicular modalities, have been proposed so far, such as: i. direct transloca-
tion from the cytoplasm across the plasma membrane by transporters; ii. uptake of proteins into endosomes or 
lysosomes followed by their fusion with the plasma membrane; iii. plasma membrane blebbing followed by the 
shedding of extracellular vesicles10–12. More recently, it has been shown that also autophagy might be involved 
and contribute to UPS: indeed, the exosomes-mediated secretion requires first the fusion of autophagosomes with 
multi-vesicular bodies (MVBs) and then the fusion with the plasma membrane13,14. In particular, acyl coenzyme 
A-binding protein 1 (Acb1) requires autophagy genes as well as the plasma membrane t-SNARE Sso1 for the 
fusion and release of the Acb1-containing vesicles into the extracellular space15.
α-Crystallin B (CRYAB or HspB5) belongs to the group of small heat shock proteins (sHSPs, molecular mass 
15–30 kDa). It forms functional oligomers (both homo- and hetero-oligomers), comprising up to 50 subunits 
and its chaperone activity consists in binding to either cytosolic or transmembrane proteins and preventing their 
aggregation through an ATP-independent holdase activity16–19. Besides the crucial role for vision in retinal cells, 
as a chaperone protein CRYAB exerts many other important protective functions in other tissues by interacting 
with the proteasome and the cytoskeleton and also by preventing apoptosis20,21. Indeed, malfunctions of CRYAB 
have been associated to myopathy, neuropathy, ischemia, cataract and cancer22–25. In addition, a neuroprotective 
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role has been demonstrated for α-Crystallin B (CRYAB) in the context of Parkinson disease, where it is found 
as major component of the intracellular Lewy bodies26. Intriguingly, a recent report has shown that CRYAB can 
exert a protective function also in the extracellular compartment, following to its exosome-dependent secretion 
from polarized human RPE cells, which is mediated by an UPS pathway that involves multi-vesicular-bodies 
(MVB)27. As such, secreted CRYAB has been shown to have a direct role for multiple sclerosis by exerting 
immuno-modulatory and pro-inflammatory effects26.
The required molecular mechanisms and the regulatory steps underlying the secretion pathway of CRYAB are 
still unknown. In this work, we present evidences that the autophagic pathway is a necessary route to guarantee 
the unconventional secretion of CRYAB. In addition, we highlight the phosphorylation on a key serine residue 
of the protein as a crucial negative regulator for its recruitment into autophagosome and consequent secretion.
Results
CRYAB is secreted by unconventional pathway from COS-7 cells. In order to study the molecular 
mechanisms involved in CRYAB secretion, we used the monkey kidney fibroblast COS-7 cell line that endoge-
nously express CRYAB (Fig. S1). To quantify and verify the secretion efficiency of both endogenous and trans-
fected forms of CRYAB, COS-7 cells were transiently transfected with 3xFlag-CRYAB and after an over-night 
incubation at 37 °C the medium was replaced with DMEM supplemented with 1% FBS and 1% l-Glutamine 
(Gln). After 6 hours, equal volumes of each medium and lysate were separated by SDS-PAGE and endogenous 
and over-expressed CRYAB were detected by using a mouse monoclonal anti-CRYAB and anti-FLAG antibodies, 
respectively. As shown in Fig. S2a, both endogenous and transfected form of CRYAB were detected in culture 
medium and the efficiency of secretion was quantified as a ratio between extracellular (OUT) and intracellular 
(IN) fractions. The histogram on the right of the upper panel showed a comparable secretion efficiency of both 
forms. Hence, and in view of its easier detection as opposed to the endogenous protein, we decided to use the 
N-terminally 3xFlag-tagged form of CRYAB for the next set of experiments.
To verify that CRYAB is secreted by unconventional secretion, COS-7 cells were transiently transfected with 
3xFlag-CRYAB. After 42 hours cells were treated with 5 μg/ml Brefeldin A (BFA) for 6 hours and equal volumes 
of each medium and lysate were separated by SDS-PAGE and the proteins were detected by immunoblotting. 
Compared to control cells (BFA-), BFA treatment (BFA+) caused the expected and extensive tubulation/fragmen-
tation of the Golgi complex28, as evidenced by GM130 staining shown in Fig. S2b (right panel). Nonetheless, in 
this condition the secretion of CRYAB was not affected (Fig. S2b, left panels), suggesting that its secretion might 
not rely on the activity of the canonical secretory pathway.
Finally, to assess whether unconventional secretion of CRYAB could be consequent to the release of exosomes 
from the cells, COS-7 cells were transiently transfected with 3xFlag-CRYAB and after 48 hours cell culture super-
natant was subjected to exosomes isolation by differential centrifugation as previously described29. Proteins 
were then resolved by SDS-PAGE and CRYAB ultimately revealed by using an anti-FLAG antibody. As shown in 
Fig. S2c, CRYAB was mainly detected in P100 fraction (exosomes), while pre-incubation with the Triton X-100 
detergent resulted in a shift of CRYAB in the S100 fraction (i.e., solubilized exosomes), therefore indicating that 
CRYAB was present in membrane vesicles.
the autophagic pathway is required for cRYAB unconventional secretion. As previously 
reported, CRYAB is secreted by RPE cells in a Multi-Vesicular Bodies (MVB)-dependent manner27. However, a 
growing body of evidences derived from studies conducted both in yeast and in mammalian cell-based systems 
support the involvement of autophagic pathway in UPS11,13,14. In particular, it has been proposed that proteins 
can be initially recruited into phagophores, during the early steps of autophagosome formation. The second step 
consists in the subsequent fusion of these compartments with MVBs, followed by their fusion with plasma mem-
brane that eventually leads to the release of the bodies out of the cells30. To investigate whether autophagic path-
way might be involved in the unconventional secretion of CRYAB, COS-7 cells were transiently transfected with 
3xFlag-CRYAB in the presence or in the absence of the siRNA against Beclin-1, a key regulator of the autophagic 
pathway activity31 (Fig. 1a). As expected, in the presence of the specific siRNA, both the Beclin-1 protein (histo-
gram in the middle) and the phosphatidylethanolamine (PE)-conjugated form of LC3 (LC3-II) levels were drasti-
cally reduced, indicating that the autophagic pathway was efficiently inhibited. Interestingly, in this condition the 
amount of secreted CRYAB was clearly reduced by about 50% (histogram on the left). Conversely, treatment with 
the known autophagy inducer rapamycin, increased both the level of the LC3-II (Fig. 1b, histogram on the right) 
and CRYAB secretion, compared to untreated cells (Fig. 1b, histogram on the left).
Finally, in order to assess whether a more physiologic induction of autophagy may influence the unconven-
tional secretion rate of CRYAB, HeLa cells were transiently transfected with 3xFlag-CRYAB and after 24 hours 
were subjected to full amino acids starvation, by incubating cells with HBSS medium, as previously reported32. As 
reported in Fig. 1c,f, following to 4 hours of treatment with HBSS buffer (+HBSS), the rate of CRYAB secretion 
was highly increased (about 6-fold), compared to cells kept in full medium (−HBSS). Noteworthy, full amino 
acids starvation (4 hours HBSS) reduced LC3-II protein levels, likely as a consequence of an increased LC3-II 
turnover by autophagic flux induction, as previously reported33–35, whereas, upon CRYAB over-expression, 
such a reduction was less pronounced (Fig. 1d). In addition, it was possible to detect a significant, albeit small, 
proportion of LC3-II (i.e. autophagosomes) in conditioned culture medium obtained from cells grown in 
full medium conditions (Fig. 1d, higher exposure), with such proportion being increased by HBSS treatment 
(Fig. 1e,f). In order to further corroborate these observations, we used two different approaches. Firstly, we did 
perform siRNA-mediated knock-down experiments by depleting either Atg5 or Atg7/10 in combination, which 
are key autophagy genes whose activity is essential for regulating the early step of autophagosome biogenesis. 
As expected, we could appreciate the reduction of Atg5 (and of the critical Atg5/12 conjugate) (Fig. 1g, middle 
panel), as well as a significant reduction in LC3-II levels (Fig. 1g, bottom panel). In both cases, as opposed to 
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Figure 1. Unconventional secretion of endogenous CRYAB requires autophagic pathway. (a–c) COS-7 cells 
were transiently transfected with 3xFlag-CRYAB and 48 hours post-transfection the lysates were separated on 
SDS-PAGE and the proteins were revealed by using the antibodies indicated on the right of the gels. CRYAB 
secretion rate was estimated in co-transfected cells with siBECN-1 or siCTRL (a), after Rapamycin (b) or HBSS 
treatment (c). (d–f) The graph in (d) reports the quantitative analysis of LC3-II levels expressed as relative 
ratio to loading control. The graphs in (e,f) report the LC3-II and 3xFlag-CRYAB levels expressed as relative 
ratio between extracellular (OUT) and intracellular (IN) pool. The P value for assessing the effect of autophagy 
inhibition on CRYAB secretion was determined using Student’s t-test (n = 3; NS = non-significant). (g–i) COS-7 
cells were transfected for 72 hours with 100 nM of control siRNA or siRNAs against either Atg5 or Atg7/10 
to inhibit autophagosome biogenesis. The intracellular and extracellular fractions were collected in the last 
6 hours. The graphs in (h,i) reports the quantitative analysis of endogenous CRYAB levels expressed as relative 
ratio between extracellular (OUT) and intracellular (IN) pool. The P value for assessing the effect of autophagy 
inhibition on CRYAB secretion was determined using Student’s t-test (n = 3; NS = non-significant). (j,k) COS-7 
cells seeded on 6-multiwell were treated for 6 hours with DMSO, rapamycin, the VPS34-IN1 inhibitor or the 
combination of both (rap/VPS34-IN1). The graph reports the quantitative analysis of endogenous CRYAB levels 
expressed as relative ratio between extracellular (OUT) and intracellular (IN) pool. The P value for assessing the 
effect of autophagy modulation on CRYAB secretion was determined using Student’s t-test.
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control knock-down cells, we observed a significant reduction in the fraction of endogenous CRYAB secreted by 
COS-7 cells. (Fig. 1g–i).
As a complementary approach, we used Vps34-IN136, a well characterized selective inhibitor of the Class-III 
PI3Kinase Vps34, which drives PI3P synthesis and is required for the assembly of the phagophore. As expected, 
we could observe an early-onset and substantial reduction of autophagosome synthesis (about 50%), by using a 
1μM concentration of the Vps34-IN1 inhibitor for 6 hours, both in HeLa and COS-7 cells (Fig. S3). In the same 
experimental setting, we could observe how the VPS34-IN1 treatment was able to reduce the secretion of endog-
enous CRYAB in COS-7 cells, compared to DMSO-treated cells. More importantly, Vps34-IN1 was also able 
to effectively antagonize the (rapamycin-induced) increased secretion of CRYAB (Fig. 1j,k). All together, these 
results strongly suggest the involvement of the autophagic pathway in the unconventional secretion of CRYAB.
CRYAB over-expression prevents autophagosomes fusion with lysosomes. To test whether 
CRYAB over-expression might have an effect on autophagosome synthesis, we used two different approaches. 
First, we measured LC3-II/tubulin relative levels, clamping or not the LC3-II/autophagosome degradation with 
the lysosomal proton pump inhibitor Bafilomycin A1. In either HeLa (Fig. 2a,b) or COS-7 cells (Fig. 2c,d), CRYAB 
over-expression increased, compared to mock-transfected cells, the steady-state levels of LC3-II, but without 
causing any further increase in Bafilomycin A1-treated cells. Thus, we reasoned that CRYAB over-expression 
could somehow reduce the LC3-II turnover and degradation37.
Then, in order to further elucidate how CRYAB over-expression could influence autophagic flux, we moved 
to the HeLa cells stably expressing the RFP-GFP-LC3 reporter38. Based on the large difference of the pKa value 
of the two fluorescent proteins, this construct can be used as a probe for autophagosome maturation. At phys-
iological pH (i.e. in newly formed autophagosomes) both fluorescent proteins are stable, leading to emission 
of red and green fluorescence. Upon acidification (after fusion with the lysosome), the green fluorescence is 
rapidly lost because of the high pKa of the GFP reporter and only red fluorescence remains (Fig. 2e). Since at the 
steady state, both LC3 and CRYAB proteins show a largely cytosolic (i.e. non-membrane associated) localization 
(Fig. S3, left panels), which could have certainly affected the co-localization analysis, cells were firstly subjected 
to a semi-permeabilization step by digitonin treatment, as previously described39. Such procedure allows one to 
substantially reduce the diffuse background staining deriving from the non-membrane associated fraction of 
both CRYAB and LC3. Nonetheless, the nuclear as well as the vesicular localization of the two proteins was still 
preserved (Fig. S3, right panels).
As shown in Fig. 2g, CRYAB over-expressing cells showed an increased number of autophagosomes 
(RFP+-GFP+ structures) and a reduced number of autolysosomes (RFP+-GFP− structures, Fig. 2f). Interestingly, 
we also noticed that CRYAB strongly co-localized with LC3 positive structures (please, see the merge panel in 
Fig. 2g). These observations are consistent with the effect of CRYAB over-expression on the increased LC3-II 
protein level (Fig. 2a–d). Such an effect may be due either to the inhibition of lysosomes acidification or fusion 
of autophagosomes with lysosomes. In order to discriminate between these two possibilities, we analyzed the 
co-localization of LC3 with the late endo-lysosomal membranes marker Lamp-1 by confocal immunofluorescence 
microscopy. As shown in Fig. 3, in empty vector transfected cells the RFP+-GFP−−LC3 autolysosomes showed 
an extensive co-localization with Lamp-1, indicating that autophagosomes were able to fuse with lysosomes. In 
contrast, upon CRYAB over-expression, the number of RFP+-GFP−-LC3 autolysosomes was reduced (consistent 
with the effect shown in Fig. 2f,g) and, most importantly did not co-localize with Lamp-1. Furthermore, the 
RFP+-GFP+-LC3 autophagosomes did co-localize with Lamp-1 to a lesser extent (Fig. 3, please refer to the mag-
nified inserts), compared to the mock transfected cells. These data strongly support that CRYAB over-expression 
reduces the fusion of autophagosomes with lysosomes.
Autophagy modulation does not influence the rate of MVB-mediated secretion. In view of the 
intimate correlation existing between the endo-lysosomal and autophagosomal pathways in mammalian cells, 
we decided to further characterize the trafficking intersections which have been recently described in the context 
of unconventional secretion. In particular, we set out to assess whether the modulation of autophagic pathway 
could provide a functional bridge and contribute to the exosome-dependent secretion of CRYAB, which involves 
the delivery to and through the multi-vesicular-bodies (MVB) membrane system27. To this aim we did perform 
confocal imaging analysis of 3xFlag-CRYAB in HeLa cells transiently over-expressing GFP-CD63, a well-known 
marker of MVB bodies40. As expected, by looking at the intracellular distribution of CRYAB positive structures 
(upon digitonin semi-permeabilization), in steady-state conditions we could observe only a partial co-localization 
between CRYAB and CD63-positive structures Fig. 4a–e), likely because of the transient presence of CRYAB in 
those structures. Such an observation is in agreement with the previously published literature, linking the exoso-
mal pathway to the unconventional secretion of CRYAB. Furthermore, we showed how upon induction of auto-
phagy by either HBSS or rapamycin (RAPA), this effect was more pronounced (Fig. 4b,c,e). However, we went 
on to assess the effect of autophagy perturbation on the MVB-mediated secretion and we found some surprising 
results. Indeed, by measuring the amount of GFP-CD63 secreted in Hela cells depleted of either Atg5 or Atg7/10 
to inhibit autophagosome biogenesis, we did not observe any reduction, compared to control cells (Fig. S5). On 
the same line, the chemical inhibition (by means of the Vps34-IN1) or activation (by rapamycin) of the pathway 
did not show any significant change in the amount of CD63 secreted in the extracellular compartment (Fig. S6).
Hence, we can confirm the existence of a functional intersection between the autophagosomal and 
MVB-membrane systems, which is corroborated by our confocal imaging analysis (Fig. 4a–c). Nevertheless, at 
least in our experimental set-up, the modulation of the autophagic pathway, albeit being capable of varying the 
amount of (both endogenous and exogenous) secreted CRYAB (please, refer to Fig. 1g–m), does not have any 
overt effect on the exosomal secretion, as assessed by measuring the fraction of GFP-CD63 positive structures 
secreted out of the cells (Figs S5 and S6).
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Figure 2. CRYAB over-expression reduces turnover of LC3-II. HeLa (a) or COS-7 (c) were transiently 
transfected with 3xFlag-CRYAB and 48 hours post-transfection cells were treated with Bafilomycin A1 for 
4 hours and lysates were separated on SDS-PAGE. Proteins were revealed by using the antibodies indicated 
on the right side of the gels. The histograms (b,d) indicate LC3-II protein levels (*P value < 0.001; ns = not 
statistically significant). (e) Schematic view of traffic-light assay. (f,g) HeLa cells, stably expressing RFP-
GFP-LC3 protein, were transiently transfected with 3xFlag-CRYAB and after 48 hours were fixed, subjected to 
the Immunofluorescence and analysed by confocal microscopy. RFP-LC3, GFP-LC3, CRYAB or merge signals 
were indicated on the top of the panels. Single focal sections are shown. Scale bar: 10 μm.
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Serine 59 negatively regulates CRYAB secretion. CRYAB bears three serine residues that can 
undergo phosphorylation, namely: Ser19, for which the kinase is not known, Ser45 and Ser59, which can be 
phosphorylated by p44/42 mitogen-activated protein kinase and MAP kinase-activated protein kinase-2 (p38), 
respectively41,42. As previously shown, the phosphorylation switch on these sites do confer a different subcellu-
lar localization in cultured hippocampal neurons43 and influence its chaperone-like activity19,44,45. In order to 
investigate whether CRYAB phosphorylation could also influence its secretion rate, we generated by site-direct 
mutagenesis (as detailed in the Materials and Methods section) the three single not-phosphorylatable mutants 
S19A, S45A, S59A, as well as the triple mutant S19A/S45A/S59A (3A). On the other hand, in order to avoid any 
possible biological output generated by cellular signaling events affecting at the same time multiple phospho-
rylation sites, the three single pseudo-phosphorylated mutants (S19D, S45D and S59D), as well as the triple 
mutant S19D/S45D/S59D (3D), were generated (Fig. S7) on the 3A background. As shown in Fig. 5a, abolishing 
phosphorylation either in position 19 or 45 showed a minor effect on CRYAB secretion, whereas the S59A (as 
well as the 3A) mutant showed a hugely increased level of secretion (about 2-fold), compared to the wild-type 
CRYAB-transfected cells. Interestingly, neither the S19D nor the S45D substitutions were able to decrease the 
secretion of the non-phosphorylatable 3A mutant, whereas either S59D or 3D mutant almost abolished CRYAB 
secretion, compared to wild-type CRYAB (Fig. 5b).
Then, in order to investigate whether the observed difference in secretion might be due to a different recruit-
ment of CRYAB into autophagosomes, HeLa cells stably expressing RFP-GFP-LC3 were transiently trans-
fected with either the wild-type 3xFlag-CRYAB or its not-phosphorylatable/pseudo-phosphorylated mutants. 
Interestingly, the not-phosphorylatable S59A mutant showed a higher co-localization with autophagosomal 
structures (Fig. 5c,e), whereas the pseudo-phosphorylated S59D mutant showed, compared to the wild-type 
CRYAB, an overall similar association and co-distribution with LC3-postive structures (Fig. 5c,e). Likewise, the 
same approach was applied in COS-7 cells co-transfected with GFP-LC3 in combination with either wild-type 
or mutant CRYAB isoforms and the co-localization was assessed and expressed as the number of GFP-LC3 dots 
positive for CRYAB (Fig. S8a,b).
Figure 3. Autophagosomes containing CRYAB do not fuse with lysosomes. (a,b) HeLa cells, stably expressing 
RFP-GFP-LC3 protein, were transiently transfected as indicated on the left of the panels and 48 hours post-
transfection were fixed and processed for the immunofluorescence by using a mouse monoclonal anti-Lamp-1 
antibody (marker of the late endosome/lysosomal compartment). Single focal sections are shown. Scale bar: 
10 μm. (c) Quantification of RFP+-GFP−-LC3 co-localization with late endosomal marker Lamp1. The analysis 
was performed using the JaCoP plug-in (ImageJ). The co-localization was calculated by using the Mander’s 
co-localization coefficient. The graph shows the normalized values of coefficients, where the co-localization 
between RFP+-GFP−-LC3 and Lamp1 was set to 1. The p values were determined by using Student’s t-test 
(n = 30 from three independent experiments; *P < 0.001). (d) The percentage of autolysosomes was calculated 
measuring the number of RFP+-GFP−-LC3 positive structures. The graph shows the normalized values relative 
to the number of RFP+-GFP−-LC3 structures before and after 3xFlag-CRYAB over-expression. The p values 
were determined as in (c).
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Figure 4. Autophagy modulation does not influence the rate of MVB-mediated secretion. HeLa cells were 
transiently transfected with the 3xFLAG-CRYAB and GFP-CD63 over-expression constructs as indicated on 
the left of the panels and 48 hours post-transfection were fixed and processed for immunofluorescence analysis 
by using a mouse monoclonal anti-LC3 and the mouse monoclonal anti-FLAG antibodies. Single focal sections 
of mock (a), HBSS (b) or rapamycin (RAPA) (c) treated cells acquired by confocal microscopy are shown. 
Scale bar: 10 μm. (d,e) Quantification of colocalization between GFP-CD63 and LC3 (d) or CRYAB (e). The 
co-localization coefficients were shown as normalized values as in Fig. 3. The p values were determined by using 
Student’s t-test (n = 30 from three independent experiments; *P < 0.001).
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Figure 5. Serine 59 controls CRYAB secretion. (a,b) Equal amount of both cell lysates and extracellular 
media of COS-7 cells transiently transfected with wyld type 3xFlag-CRYAB or its not-phosphorylatable/
pseudo-phosphorylated mutants were analysed by SDS-PAGE and CRYAB proteins were revealed by using 
a mouse monoclonal anti-Flag antibody. (c,d) HeLa cells, stably expressing RFP-GFP-LC3 protein, were 
transiently transfected with the indicated constructs and after 40 hours were fixed and subjected to the 
immunofluorescence by using a mouse monoclonal anti-Flag antibody to recognize CRYAB proteins while 
LC3 proteins were detected by auto-fluorescence for the presence of GFP- and RFP-tagged proteins. (e) 
Quantification of RFP-GFP-LC3 co-localization with wild type and mutant forms of CRYAB. The analysis was 
performed using the JaCoP plug-in (ImageJ). The co-localization between CRYAB and LC3-positive structures 
were calculated by using the Mander’s co-localization coefficient. The graph shows the normalized values of 
coefficients, where the co-localization between LC3 and wild type CRYAB was set to 1. The p values for assessing 
the RFP-GFP-LC3 and CRYAB co-localization were determined by using Student’s t-test (n = 10; ***P < 0.001; 
**P < 0.01; *P < 0.05; NS: not-significant). A single focal section is shown. Scale bar: 10 μm.
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Moreover, we found that the disease-associated CRYAB-R120G mutant, which is defective in its chaperone 
activity18,46, was not secreted by COS-7 cells (Fig. 5a,b). In consideration of its spontaneous tendency to form 
insoluble cytosolic aggregates, its over-expression was found to cause a marked increase of autolysosomes (Fig. 5d) 
and, as one would expect for an autophagic substrate, a reduced co-localization with the autophagosome-positive 
structures (Figs 5e and S9a). This result prompted us to understand whether the R120G mutant was not capable 
to divert autophagosomes toward the exocytic pathway because it is a substrate of autophagy-dependent deg-
radation pathway and, as such, not secreted by the cell. In order to address such a possibility, we did perform 
substrate clearance experiments in HeLa cells over-expressing the 3xFlag-CRYAB-R120G mutant, by inducing 
(or blocking) autophagy with trehalose or bafilomycin A1, respectively (Fig. S9b,c). Notably, in these experiments 
we also monitored the clearance of the Parkinson’s disease-associated A53T α-synuclein mutant, a known auto-
phagy substrate, whose intracellular levels mirror the activity of the autophagic pathway47. Differently from the 
expression levels of A53T α-synuclein, neither trehalose nor bafilomycin A1 were able to significantly change the 
levels of CRYAB-R120G mutant (Fig. S9b,c). Therefore, the turn-over of the CRYAB-R120G mutant protein does 
not rely on the autophagic pathway.
All together, these results indicate that CRYAB secretion is negatively regulated by the phosphorylation state of 
its Serine 59 residue, which hampers the recruitment of the protein into autophagosomal structures.
Discussion
To our knowledge, this is the first systematic study in mammalian cells that links the phosphorylation-dependent 
unconventional secretion of α-Crystallin B (CRYAB), a member of the small heat-shock proteins (sHsp) super-
family with chaperone activity48, to the activity of the autophagic pathway. More specifically, the characteriza-
tion of the mechanisms regulating the secretion of α-Crystallin B has led us to three key findings: i. CRYAB is 
unconventionally secreted in autophagy-dependent manner; ii. when recruited, CRYAB is capable to highjack 
and divert autophagosomes from the canonical route (leading to the lysosomal compartment) toward the exo-
cytic pathway; iii. the phosphorylation state of the CRYAB serine 59 residue can regulate its own secretion by 
influencing the recruitment to the autophagosomal structures.
the autophagic pathway contributes to cRYAB unconventional secretion. We report evidences 
that CRYAB can be actively secreted in exocytic vesicles. Moreover, the rate of CRYAB secretion can be main-
tained irrespectively of the activity of the canonical secretory pathway (brefeldin-A treatment, Fig. S1). In mam-
malian cells, autophagy occurs under basal conditions and can be induced by certain environmental stresses, such 
as nutrient deprivation, infections, oxidative stress. In starvation conditions, autophagy is induced and increases 
the availability of nutrients by promoting their release from macromolecules that are targeted for degradation49. 
Although autophagy has been considered in the past as a rather non-selective degradative process, several 
cargo-specific autophagic processes have been more recently described49. In addition, autophagy intersects and 
share many molecular players with multiple steps of both the endocytic and exocytic pathways50. For instance, 
autophagy has been shown to modulate both constitutive and regulated secretion of some immuno-modulatory 
cytokines51. Interestingly, autophagy can play a role also in the unconventional trafficking of the cystic fibrosis 
transmembrane conductance regulator (CFTR, the protein mutated in cystic fibrosis) from the ER to the plasma 
membrane, bypassing the Golgi52. Finally, a subset of leaderless proteins can use unconventional secretion pro-
cesses that rely on autophagic intermediates, structures or vesicular transport carriers, in order to be exported 
outside the cell14. According to our data, CRYAB might be included into the latter category. Indeed, by means of 
multiple siRNA-based knock-down experiments (Fig. 1g–i), we demonstrated that the basal autophagy contrib-
utes to guarantee CRYAB secretion in steady-state conditions. Conversely, by using two different experimental 
approaches (i.e. induction of autophagy with rapamycin or nutrients starvation with HBSS), we showed that 
the activation of autophagy can substantially promote CRYAB secretion in our cell-based systems. Finally, by 
chemically inhibiting the early step of autophagosome biogenesis, we show that autophagy is required for the 
unconventional secretion of endogenous CRYAB, both at steady-state and in stimulated conditions (Fig. 1j,k).
CRYAB can divert autophagosomes toward the extracellular compartment. In view of our first 
line of evidences (Fig. 1), it would have been reasonable to hypothesize that CRYAB over-expression might induce 
per se autophagosome formation. Indeed, we observed a consistent increase in both the LC3-II levels and number 
of autophagosomes in CRYAB over-expressing cells (Fig. 2). Moreover, most of the autophagosomes resulted 
positive for CRYAB. An increase in levels of LC3-II can be consequent to either an increased autophagosome 
formation or a block in autophagosome maturation or degradation. Furthermore, the latter possibility could be 
explained by a block in autophagosome-lysosome fusion, a defect in lysosomal degradation (which would inevita-
bly reduce the turn-over of autophagosomes), or both. Surprisingly, we found a reduced co-localization between 
autophagosomes (mostly CRYAB-positive) and the lysosomal compartment, as assessed by endogenous Lamp-1 
staining, suggesting that CRYAB delays the delivery (or inhibits the fusion) of autophagosomes with lysosomes 
(Fig. 3). Nonetheless, we reasoned that the only mild, albeit consistent, increase in the amount of LC3-II levels 
observed in CRYAB over-expressing cells would not be compatible with the drastically detrimental effects on 
LC3-II/autophagosomes turn-over one would expect from a block in the later state of autophagy, as it has been 
previously reported38,53.
Such an interesting observation, combined with the active role exerted by autophagy in regulating CRYAB 
secretion, would be rather compatible with a hypothetical model whereby CRYAB-positive autophagosomes are 
diverted from the classical route leading to the lysosomal compartment and re-directed toward to the exocytic 
pathway/plasma membrane, in order to facilitate the secretion of their content. In agreement with these obser-
vations, we showed how a substantial portion of the intracellular pool of CRYAB does indeed co-localize with 
the MVB-marker CD63 (Fig. 4), a phenomenon which is even more pronounced upon autophagy stimulation. 
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Hence, it is conceivable to speculate that a specific subset of trafficking autophagosomes being diverted from 
the lysosomal degradative system toward secretion routs might well be reaching the MVB-exocytic membrane 
system. Moreover, this scenario would not be in contradiction with a previous study, reporting that CRYAB 
is apically secreted by polarized epithelial RPE cells in a multi-vesicular bodies (MVB)-dependent manner27. 
Collectively, our data confirm the existence of a functional intersection between the autophagosomal and 
MVB-membrane systems. However, the modulation of the autophagic pathway, albeit being capable of varying 
the amount of secreted CRYAB does not have any overt effect on the MVB-mediated unconventional exosomal 
secretion. Further experiments will be required in order to shed light and address these interesting issues regard-
ing the interplay between the autophagic and MVB-mediated exocytic pathways.
Impact of serine 59 phosphorylation on CRYAB secretion. In mammalian cells, heat-shock proteins 
are mainly localized in the cytosol. Phosphorylation appears to be one of the critical modulators of chaperone 
functions of small heat shock proteins. However, the role of phosphorylation in regulating CRYAB activity is 
still not completely understood. In recent years, several studies have investigated the structural and functional 
consequences of a phosphorylation-mimicking mutation in α-Crystallin B. For instance, the phosphorylation 
at three serine residues (Ser19, Ser45 and Ser59) represents a major post-translational modification that occurs 
to alpha B-crystallin in response to stress or during mitosis42,44. Furthermore, it has been recently suggested 
that phosphorylation of α-Crystallin B can account for changes in stability, homo- and hetero-oligomerization 
properties and reduction of its chaperone-like activity19,45. Therefore, we aimed at investigating whether change 
in phosphorylation state could also influence CRYAB secretion rate. By means of site-directed mutagenesis, we 
identified the serine 59 as the critical residue in regulating the recruitment into autophagosomal structures and, 
as a consequence, the secretion rate of CRYAB (Fig. 5). Therefore, it is tempting to hypothesize the existence of 
a selective, phosphorylation-based mechanism that allows, when necessary, the autophagy-dependent uncon-
ventional transport of a specific subset of proteins (including CRYAB), which have to be secreted out of the cell. 
Notably, and according to some of our data, this scenario could apply also to physiologically relevant conditions, 
such as in response to nutrient starvation. For instance, it has been reported that in response to nutrient starva-
tion, members of the p38 mitogen-activated protein kinase (MAPK) signaling pathway MAPKAPK2 (MK2) and 
MAPKAPK3 (MK3) are crucial stress-responsive kinases that promote autophagy through Beclin-1 S90 phospho-
rylation54. Interestingly, the same kinase family members are responsible for the S59 CRYAB phosphorylation42, 
thereby strongly suggesting that these two events are very likely functionally correlated. Further experiments will 
be required to better address such an interesting possibility.
Potential implications of CRYAB secretion in the context of disease-associated mutant pro-
teins turn-over. Finally, our findings could be potentially relevant for a number of disease models. For 
instance, anti-apoptotic and neuroprotective functions have been proposed for the α-Crystallin B (CRYAB) in the 
development of multiple sclerosis (MS). In particular, in early-phase active MS lesions, extracellular α-Crystallin 
B is available for functional presentation to T-cells during the inflammatory demyelination process55–57. In this 
context, CRYAB represents a potent negative regulator acting as a brake on several pro-inflammatory pathways in 
both the immune system and central nervous system. In the context of multiple sclerosis, the immune response 
against CRYAB exacerbate inflammation and demyelination in vivo and is overall detrimental for the pathological 
outcome26. Thus, administration of recombinant CRYAB has been proposed for therapy of ongoing disease. As a 
further example, α-Crystallin B has been found, along with α-synuclein, as a major component of Lewy bodies 
that are characteristic of Parkinson’s disease (PD). CRYAB is a potent inhibitor of α-synuclein amyloid fibrils 
formation58,59. The two mutant forms (A30P and A53T) of α-synuclein, that are causative of familial, early-onset 
forms of PD, are autophagy substrates and pharmacological up-regulation of autophagy has been shown to 
enhance the clearance of these mutant proteins, resulting beneficial in the progression of several neurodegener-
ative disease models49. Therefore, the novel mechanism we describe here, by which α-Crystallin B (and its inter-
acting proteins) is recruited in autophagosomes, might be relevant and deserves further investigations, as it could 
represent an additional “back-up” system by which cells are able to cope with and alleviate the accumulation of 
intracellular mutant, aggregate-prone or misfolded proteins. As such, this could ultimately limit the pathogenesis 
and the onset of misfolding diseases, and in perspective, represent a potential target to develop novel therapeutic 
intervention.
Materials and Methods
Reagents. All of the culture reagents were obtained from Sigma-Aldrich (Milan, Italy). The solid chemical 
and liquid reagents were obtained from E. Merck (Darmstadt, Germany), Farmitalia Carlo Erba (Milan, Italy), 
Serva Feinbiochemica (Heidelberg, Germany), Delchimica (Naples, Italy) and BDH (Poole, United Kingdom). 
Protein A-Sepharose CL-4B and the enhanced chemiluminescence reagents were from Roche (Milan, Italy). 
Brefeldin-A (BFA), digitonin, rapamycin, bafilomycin A1, trehalose and cycloheximide were purchased from 
Sigma-Aldrich, Milan, Italy. The Vps34-IN1 inhibitor (CAS № 1383716-33-3) was purchased from Cayman 
Chemicals (Ann Arbor, Michigan-USA).
Antibodies. The following antibodies were used: Peroxidase conjugated anti-mouse and anti-rabbit IgG 
(Sigma-Aldrich, Milan, Italy); Texas-Red-conjugated anti-mouse and anti-rabbit IgG, FITC-conjugated goat 
anti-mouse and anti-rabbit IgG, Cy5-conjugated goat anti-mouse and anti-rabbit IgG (Jackson ImmunoResearch 
Laboratories, West Grove, PA); Mouse monoclonal anti-FLAG antibody (Sigma-Aldrich, Milan, Italy); Mouse 
monoclonal anti-CRYAB antibody (Enzo Life Sciences, USA). Mouse monoclonal anti-α-tubulin antibody 
(Sigma-Aldrich, Milan, Italy); Rabbit polyclonal anti-LC3 antibody (Novus Biologicals); Mouse monoclo-
nal anti-LC3 antibody (NanoTools); Mouse monoclonal anti-CD7107a (Lamp-1) antibody (Biolegend, San 
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Diego, CA); Rabbit polyclonal anti-BECN1 (Santa Cruz Biotechnology); rabbit polyclonal anti-GFP antibody 
(AbCam); rabbit polyclonal anti-Atg5 antibody (AbCam). Rabbit polyclonal anti-GM130 antibody was described 
previously60.
Constructs, siRNA reagents, cDNA cloning and plasmid construction. The pCMV6-XL5 expres-
sion vector for human CRYAB protein (ID NM_001885.1) was obtained from I.M.A.G.E. Consortium. To gen-
erate the 3xFlag-CRYAB construct, the cDNA coding for CRYAB was amplified by PCR from the pCMV6-XL5 
plasmid using the following primers (containing HindIII/XbaI flanking restriction sites) and cloned into the 
p3xFlag-CMV-7.1 expression vector: Fw (HindIII): 5′-AAGCTTATGGACATCGCCATCCACCACCC-3′; 
Rv (XbaI): 5′-TCTAGACTATTTCTTGGGGGCTGCGG-3′. To obtain the 3xFlag-CRYAB-R120G construct, 
in which the R120 was substituted with a glycine residue (G), the construct 3xFlag-CRYAB was used as a tem-
plate and site-direct mutagenesis was performed according to the manufacturer instructions and as previously 
reported61,62 by using the following primers: Fw: 5′-CTCCAGGGAGTTCCACGGGAAATACCGGATCCCAG
-3′; Rv: 5′-GTGGAACTCCCTGGAGATGAAACC-3′. To generate the CRYAB mutant constructs carrying 
the not-phosphorylatable sites (S19A, S45A, S59A and S19/45/59A), the following primers were used: Fw: 
CTTCTTTCCTTTCCACGCCCCCAGCCGCCTCTTTG; Rv: AAGAAGGGGCGGCGGATCCAG for S19A; 
Fw: CGTCTACTTCCCTGGCTCCCTTCTACCTTCGG; Rv: CAGGGAAGTAGACGTCGGGAAAAG for S45A; 
Fw: CTTCCTGCGGGCACCCGCCTGGTTTGACACTGGAC; Rv: GGGTGCCCGCAGGAAGGAGGG for 
S59A. The combination of them was used to obtain the triple mutant 3xFlag-CRYAB-S19/45/59A.
To obtain the pseudo-phosphorylated mutants of CRYAB (S19D, S45D, S59D and S19/45/59D) 
the 3xFlag-CRYAB-S19/45/59A construct was used as a template and site-direct mutagenesis was per-
formed using the following primers: Fw: CTTCTTTCCTTTCCACGACCCCAGCCGCCTCTTTG; 
Rv: AAGAAGGGGCGGCGGATCCAG for S19D; Fw: CGTCTACTTCCCTGGACCCCTTCTACCTTCGG; 
Rv: CAGGGAAGTAGACGTCGGGAAAAG for S45D; Fw: CTTCCTGCGGGCACCCGACTGGTTT 
GACACTGGAC; Rv: GGGTGCCCGCAGGAAGGAGGG for S59D. The combination of them was used to obtain 
the triple mutant 3xFlag-CRYAB-S19/45/59D construct.
For the knock-down experiments, Lipofectamine 2000 Transfection Reagent was used according to the man-
ufacturer’s instructions (Thermofisher Scientific, Cat. No.: 11668019), in combination with the following siRNAs: 
ON-TARGETplus Non-targeting Pool (Cat. No.: D-001810-10-50), SMARTpool: ON-TARGETplus ATG5 (Cat. 
No.: L-004374-00-0010), SMARTpool: ON-TARGETplus ATG7 (Cat. No.: L-020112-00-0010), SMARTpool: 
ON-TARGETplus ATG10 (Cat. No.: L-019426-01-0010) (Dharmacon, Horizon Discoveries).
The plasmid encoding GFP-CD63 was obtained from Paul Luzio’s lab (Addgene plasmid #62964). The plas-
mids encoding empty GFP (peGFP-C1, Clontech) and GFP-A53T alpha-synuclein (Addgene plasmid #40823) 
were obtained from David Rubinsztein’s lab. The peGFP-LC3 expression vector and siRNA targeting Beclin-1 
were kindly provided by Maria Fiammetta Romano63.
Cell culture and transfection experiments. HeLa and COS-7 cells were routinely grown at 37 °C in 
Dulbecco’s modified essential medium (DMEM), containing 10% foetal bovine serum (FBS), 100 U/ml Penicillin/
Streptomycin, 2 mM l-Glutamine (l-Gln). HeLa cells stably expressing the RFP-GFP-LC3 reporter39 were grown 
in the same medium, supplemented with 600 μg/ml G418 (Gibco). Cells were transfected by using FuGene 6.0 
(Roche, Milan, Italy) according to the manufacturer’s instructions. For the full amino acid starvation experi-
ments, cells were incubated for 4 hours in Hank’s Balanced Salt Solution (HBSS, Gibco-Brl).
Immunofluorescence and confocal microscopy. Indirect immunofluorescence was performed as 
previously described64–66. Single confocal images were acquired at 63x magnification on a LSM510 Meta (Carl 
Zeiss, Jena, Germany). For each co-transfection, 30 cells were considered for quantification. In traffic-light 
experiment the number of RFP+-GFP−-LC3 dots were measured as difference between RFP+-GFP−-LC3 and 
RFP+-GFP+-LC3 dots by using ImageJ Biophotonics software. For the quantification of GFP-LC3 co-localization 
with CRYAB phosphorylation mutants, the number of red dots (CRYAB) co-localizing with green dots (GFP-LC3) 
was measured by using ImageJ Biophotonics software. The results are given as mean ± s.d.
Semi-permeabilization assay by digitonin treatment. In order to better visualized the colocalization 
between GFP-LC3 and 3xFlag-CRYAB in COS-7, after 48 hrs from transfection cells were semi-permeabilized, 
as previously described39. Briefly, cells were transferred to ice and washed immediately with ice-cold KHM 
buffer (110 mM KOAc, 20 mM Hepes, pH 7.2, 2 mM MgOAc). Cells were digitonin permeabilized at 40 μg/ml in 
KHM buffer for 3 min on ice, fixed in 3,7% formaldehyde in PBS for 30 min at room temperature after wash with 
ice-cold KHM buffer and subjected to indirect immunofluorescence as described above. Single confocal images 
were acquired at 63x magnification on a LSM510 Meta (Carl Zeiss, Jena, Germany).
preparation of cell extracts, SDS-pAGe and Western Blot analysis. Preparation of cell extracts, 
SDS-PAGE and Western blot analysis were performed as previously detailed67,68.
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